AIM: To identify plasma analytes using metabolomics that correlate with the diagnosis and severity of liver disease in patients with alcoholic hepatitis(AH).MET
AIM:To achieve an evidence-based conclusion regarding the safety and efficacy of telbivudine during pregnancy.METHODS:A pooled analysis of data from a literatur
Hepatitis C virus(HCV) affects about 3% of the world’spopulation, with the highest prevalence in individuals under 40. The prevalence in pregnant women varies